Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 45.0
(0.0%)
JPY 45.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.62 Billion JPY | 29.17% |
| 2022 | -3.7 Billion JPY | -7.28% |
| 2021 | -3.45 Billion JPY | -73.75% |
| 2020 | -1.98 Billion JPY | 46.86% |
| 2019 | -3.74 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -2.2 Billion JPY | 15.99% |
| 2024 Q2 | -1.93 Billion JPY | 12.35% |
| 2023 FY | -2.62 Billion JPY | 29.17% |
| 2023 Q2 | -3.11 Billion JPY | 7.75% |
| 2023 Q1 | -3.37 Billion JPY | 8.99% |
| 2023 Q3 | -2.87 Billion JPY | 7.55% |
| 2023 Q4 | -2.62 Billion JPY | 8.74% |
| 2022 Q3 | -4.21 Billion JPY | 0.0% |
| 2022 Q4 | -3.7 Billion JPY | 12.01% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 742.75 Million JPY | 453.297% |
| PRISM BioLab Co.,LTD | -1.13 Billion JPY | -131.418% |
| GNI Group Ltd. | -17.93 Billion JPY | 85.367% |
| Linical Co., Ltd. | -4.46 Billion JPY | 41.206% |
| Trans Genic Inc. | -221.16 Million JPY | -1086.49% |
| MEDINET Co., Ltd. | -4.39 Billion JPY | 40.279% |
| Soiken Holdings Inc. | -4.79 Billion JPY | 45.216% |
| Cytori Cell Research Institute, Inc. | 1.43 Billion JPY | 283.054% |
| AnGes, Inc. | -3.79 Billion JPY | 30.903% |
| OncoTherapy Science, Inc. | -420.8 Million JPY | -523.599% |
| Nxera Pharma Co., Ltd. | 24.9 Billion JPY | 110.535% |
| Immuno-Biological Laboratories Co., Ltd. | -498.15 Million JPY | -426.774% |
| NanoCarrier Co., Ltd. | -466.34 Million JPY | -462.703% |
| Carna Biosciences, Inc. | -2.7 Billion JPY | 3.03% |
| CanBas Co., Ltd. | -1.88 Billion JPY | -38.976% |
| D. Western Therapeutics Institute, Inc. | -982.14 Million JPY | -167.186% |
| RaQualia Pharma Inc. | -3.39 Billion JPY | 22.751% |
| Chiome Bioscience Inc. | -1.03 Billion JPY | -153.65% |
| Kidswell Bio Corporation | 343.58 Million JPY | 863.746% |
| PeptiDream Inc. | 3.29 Billion JPY | 179.713% |
| Oncolys BioPharma Inc. | -972.59 Million JPY | -169.809% |
| Ribomic Inc. | -2.09 Billion JPY | -24.975% |
| SanBio Company Limited | -3.78 Billion JPY | 30.756% |
| Healios K.K. | -2.19 Billion JPY | -19.824% |
| BrightPath Biotherapeutics Co., Ltd. | -944.85 Million JPY | -177.729% |
| Delta-Fly Pharma, Inc. | -1.41 Billion JPY | -85.182% |
| StemRIM | -8.41 Billion JPY | 68.797% |
| CellSource Co., Ltd. | -4.68 Billion JPY | 43.97% |
| FunPep Company Limited | -1.79 Billion JPY | -46.324% |
| Kringle Pharma, Inc. | -2.13 Billion JPY | -22.825% |
| Stella Pharma Corporation | -1.11 Billion JPY | -134.424% |
| TMS Co., Ltd. | -3.44 Billion JPY | 23.863% |
| Noile-Immune Biotech Inc. | -5.55 Billion JPY | 52.767% |
| Cuorips Inc. | -5.56 Billion JPY | 52.812% |
| K Pharma,Inc. | -3.26 Billion JPY | 19.663% |
| Takara Bio Inc. | -32.2 Billion JPY | 91.851% |
| ReproCELL Incorporated | -2.93 Billion JPY | 10.715% |
| PhoenixBio Co., Ltd. | -660.96 Million JPY | -297.021% |
| StemCell Institute Inc. | -2.83 Billion JPY | 7.495% |
| Japan Tissue Engineering Co., Ltd. | -2.06 Billion JPY | -26.995% |
| CellSeed Inc. | -2.01 Billion JPY | -30.422% |